Uniphar PLC
LSE:UPR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Uniphar PLC
LSE:UPR
|
IE |
|
Casino Guichard Perrachon SA
PAR:CO
|
FR |
|
M
|
Major Development PCL
SET:MJD
|
TH |
Relative Value
The Relative Value of one UPR stock under the Base Case scenario is 867.56 GBX. Compared to the current market price of 342 GBX, Uniphar PLC is Undervalued by 61%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
UPR Competitors Multiples
Uniphar PLC Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IE |
U
|
Uniphar PLC
LSE:UPR
|
1B GBP | 0.3 | 19.9 | 10.4 | 14.5 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
109B USD | 0.3 | 25.1 | 17.6 | 19.8 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
64.5B USD | 0.2 | 39.7 | 14 | 17.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
63.6B USD | 0.2 | 39.2 | 13.8 | 17.5 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
49B USD | 0.2 | 29.5 | 14.3 | 18.6 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32B AUD | 2.8 | 35.1 | 26.1 | 26.1 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.4B CNY | 0.2 | 11.2 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62.5B CNY | 1.5 | 16.9 | 13.1 | 13.1 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.4B USD | 0.6 | 21 | 10.3 | 14.5 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64.9B HKD | 0.1 | 8.4 | 1.5 | 1.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |